Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lorin Randall Insider Profile
4 Followers
Lorin Randall, Director at Acorda Therapeutics, holds 0.00 shares in Acorda Therapeutics (Ticker: ACOR), holds 0.00 shares in Nanosphere (Ticker: NSPH), holds 0.00 shares in Athersys (Ticker: ATHX). Most recently, Lorin Randall Sold ― shares of Acorda Therapeutics on Nov 28, 2018 for an estimated value of 38.02K.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+6.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Lorin Randall does not currently own shares as a corporate insider.
A breakdown of Lorin Randall's holdings
Insider Roles
Roles that Lorin Randall holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 28, 2018 - Nov 28, 2019
Return:+91.50%
The most profitable trade made by Lorin Randall
Lorin Randall's Trading History
Acorda Therapeutics
Nov 28, 2018
Director
Informative Sell
38.02K
$0.00
Athersys
Aug 19, 2014
Director
Informative Sell
23.10K
$0.00
Nanosphere
Jul 01, 2016
―
Uninformative Sell
17.00K
$0.00
Acer Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Lorin Randall's performance on stock
You May Also Like
Lorin Randall insider profile FAQ
What is the percentage of profitable transactions made by Lorin Randall?
The percentage of profitable transactions made by Lorin Randall is 50%.
What is the average return per transaction made by Lorin Randall?
The average return per transaction made by Lorin Randall is 6.80%.
What stocks does Lorin Randall hold?
Lorin Randall holds: ACOR, ATHX, NSPH, ACER stocks.
What was Lorin Randall’s latest transaction?
Lorin Randall latest transaction was an Informative Sell of $38.02K.
What was Lorin Randall's most profitable transaction?
Lorin Randall’s most profitable transaction was an Informative Sell of ACOR stock on November 28, 2018. The return on the trade was 91.50%.
What is Lorin Randall's role in Acorda Therapeutics?
Lorin Randall's role in Acorda Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.